The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Development of a Multimarker Assay for Early Detection of Ovarian Cancer
Open accessAbstract
Purpose: Early detection of ovarian cancer has great promise to improve clinical outcome. Patients and Methods: Ninety-six serum biomarkers were analyzed in sera from healthy women and from patients with ovarian cancer, benign pelvic tumors, and breast, colorectal, and lung cancers, using multiplex xMAP bead-based immunoassays. A Metropolis algorithm with Monte Carlo simulation (MMC) was used for analysis of the data. Results: A training set, including sera from 139 patients with early-stage ovarian cancer, 149 patients with late-stage ovarian cancer, and 1,102 healthy women, was analyzed with MMC algorithm and cross validation to identify an optimal biomarker panel discriminating early-stage cancer from healthy controls. The four-biomarker panel providing the highest diagnostic power of 86% sensitivity (SN) for early-stage and 93% SN for late-stage ovarian cancer at 98% specificity (SP) was comprised of CA-125, HE4, CEA, and VCAM-1. This model was applied to an independent blinded validation set consisting of sera from 44 patients with early-stage ovarian cancer, 124 patients with late-stage ovarian cancer, and 929 healthy women, providing unbiased estimates of 86% SN for stage I and II and 95% SN for stage III and IV disease at 98% SP. This panel was selective for ovarian cancer showing SN of 33% for benign pelvic disease, SN of 6% for breast cancer, SN of 0% for colorectal cancer, and SN of 36% for lung cancer. Conclusion: A panel of CA-125, HE4, CEA, and VCAM-1, after additional validation, could serve as an initial stage in a screening strategy for epithelial ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Equation of State Calculations by Fast Computing Machines
Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., & Teller, E. (1953) · The Journal of Chemical Physics · doi:10.1063/1.1699114 · Cited by 37,192
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Monte Carlo Statistical Methods
Kim, H. (2000) · Technometrics · doi:10.1080/00401706.2000.10485722 · Cited by 5,508
Monte Carlo Statistical Methods
Robert, C. P., & Casella, G. (2004) · Springer Texts in Statistics · doi:10.1007/978-1-4757-4145-2 · Cited by 4,271
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Self-citationMonte Carlo: Concepts, Algorithms, and Applications
Wasserstein, R. L. (1997) · Technometrics · doi:10.1080/00401706.1997.10485133 · Cited by 1,790
The CA 125 tumour-associated antigen: a review of the literature
Jacobs, I., & Bast, R. C. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136832 · Cited by 955
Self-citationZhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Self-citationMonte Carlo: Concepts, Algorithms, and Applications
(1996) · Journal of Computational and Applied Mathematics · doi:10.1016/s0377-0427(97)80822-9 · Cited by 795
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 711
Ovarian cancer: Epidemiology, biology, and prognostic factors
Holschneider, C. H., & Berek, J. S. (2000) · Seminars in Surgical Oncology · doi:10.1002/1098-2388(200007/08)19:1<3::aid-ssu2>3.0.co;2-s · Cited by 694
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
Self-citationNew tumor markers: CA125 and beyond
BAST, R. C., BADGWELL, D., LU, Z., MARQUEZ, R., ROSEN, D., LIU, J., BAGGERLY, K. A., ATKINSON, E. N., SKATES, S., ZHANG, Z., et al. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00441.x · Cited by 504
Self-citationSerum protein markers for early detection of ovarian cancer
Mor, G., Visintin, I., Lai, Y., Zhao, H., Schwartz, P., Rutherford, T., Yue, L., Bray-Ward, P., & Ward, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502178102 · Cited by 482
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Jacobs, I. J., & Menon, U. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400006-mcp200 · Cited by 458
Self-citationSchummer, M., Ng, W. V., Bumgarner, R. E., Nelson, P. S., Schummer, B., Bednarski, D. W., Hassell, L., Baldwin, R. L., Karlan, B. Y., & Hood, L. (1999) · Gene · doi:10.1016/s0378-1119(99)00342-x · Cited by 402
Perkins, G. L., Slater, E. D., Sanders, G. K., & Prichard, J. G. (2003) · PubMed · Cited by 293
Banks, R., Gearing, A., Hemingway, I., Norfolk, D., Perren, T., & Selby, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.298 · Cited by 287
Serum Gonadotropins and Steroid Hormones and the Development of Ovarian Cancer
Helzlsouer, K. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530240036037 · Cited by 264
Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer
Gorelik, E., Landsittel, D. P., Marrangoni, A. M., Modugno, F., Velikokhatnaya, L., Winans, M. T., Bigbee, W. L., Herberman, R. B., & Lokshin, A. E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0404 · Cited by 264
Self-citationProspective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer
Menon, U., Skates, S. J., Lewis, S., Rosenthal, A. N., Rufford, B., Sibley, K., MacDonald, N., Dawnay, A., Jeyarajah, A., Bast, R. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6642 · Cited by 243
Self-citationDiamandis, E. P., Scorilas, A., Fracchioli, S., van Gramberen, M., de Bruijn, H., Henrik, A., Soosaipillai, A., Grass, L., Yousef, G. M., Stenman, U.-H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.022 · Cited by 234
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama, Y., Dhanabal, M., Griffioen, A. W., Sukhatme, V. P., & Ramakrishnan, S. (2000) · Cancer Research · Cited by 231
Clements, J. A., Willemsen, N. M., Myers, S. A., & Dong, Y. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490471931 · Cited by 220
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
McIntosh, M. W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K. E., & Hellstrom, I. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.039 · Cited by 193
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
Gadducci, A., Cosio, S., Carpi, A., Nicolini, A., & Genazzani, A. R. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.003 · Cited by 188
Human tissue kallikreins: The cancer biomarker family
Paliouras, M., Borgono, C., & Diamandis, E. P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.018 · Cited by 183
Skates, S. J., Horick, N., Yu, Y., Xu, F.-J., Berchuck, A., Havrilesky, L. J., de Bruijn, H. W. A., van der Zee, A. G. J., Woolas, R. P., Jacobs, I. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.091 · Cited by 170
Self-citationDolo, V., D'Ascenzo, S., Violini, S., Pompucci, L., Festuccia, C., Ginestra, A., Vittorelli, M. L., Canevari, S., & Pavan, A. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006500406240 · Cited by 167
SCHOEN, R., WEISSFELD, J., KULLER, L., THAETE, F., EVANS, R., HAYES, R., & ROSEN, C. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.051 · Cited by 158
Skates, S. J., Ankerst, D. P., & Jacobs, I. J. (2001) · Journal of the American Statistical Association · doi:10.1198/016214501753168145 · Cited by 150
Self-citationSerum Evaluation of Interleukin 6 in Ovarian Cancer Patients
Tempfer, C. M., Zeisler, H., Sliutz, G., Haeusler, G., Hanzal, E., & Kainz, C. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4726 · Cited by 133
Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome
van Dessel, H. J. H. M., Lee, P., Faessen, G. H., Fauser, B. C. J. M., & Giudice, L. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5941 · Cited by 129
Role of osteoprotegerin (OPG) in cancer
Holen, I., & Shipman, C. M. (2006) · Clinical Science · doi:10.1042/cs20050175 · Cited by 124
van Haaften‐Day, C., Shen, Y., Xu, F., Yu, Y., Berchuck, A., Havrilesky, L. J., de Bruijn, H. W. A., van der Zee, A. G. J., Bast, R. C., & Hacker, N. F. (2001) · Cancer · doi:10.1002/1097-0142(20011201)92:11<2837::aid-cncr10093>3.0.co;2-5 · Cited by 122
Self-citationEGF/ErbB Receptor Family in Ovarian Cancer
Maihle, N. J., Baron, A. T., Barrette, B. A., Boardman, C. H., Christensen, T. A., Cora, E. M., Faupel‐Badger, J. M., Greenwood, T. M., Juneja, S. C., Lafky, J. M., et al. (2002) · Springer eBooks · doi:10.1007/978-1-4757-3587-1_11 · Cited by 116
Yurkovetsky, Z. R., Ta’asan, S., Skates, S. J., Rand, A., Lomakin, A., Linkov, F. Y., Marrangoni, A., Velikokhatnaya, L., Winans, M., & Gorelik, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.05.041 · Cited by 109
Self-citationMoore, L. E., Fung, E. T., McGuire, M., Rabkin, C., Molinaro, A. M., Wang, Z., Zhang, F., Wang, J., Yip, C., Meng, X., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0980 · Cited by 101
Baron, A. T., Cora, E. M., Lafky, J. M., Boardman, C. H., Buenafe, M. C., RADEMAKER, A. W., Liu, D., Fishman, D. A., Podratz, K. C., & Maihle, N. J. (2003) · PubMed · Cited by 97
Macciò, A., Lai, P., Santona, M. C., et al. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.4974 · Cited by 93
Siemińśka, L., Marek, B., Kos‐Kudła, B., Niedziolka, D., Kajdaniuk, D., Nowak, M., & Głogowska-Szeląg, J. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347474 · Cited by 86
Reproducibility of serum cytokines and growth factors
Gu, Y., Zeleniuch‐Jacquotte, A., Linkov, F. Y., Koenig, K. L., Liu, M., Velikokhatnaya, L., Shore, R. E., Marrangoni, A., Toniolo, P. G., Lokshin, A. E., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2008.10.014 · Cited by 80
Self-citationOvarian Cancer Screening in the General Population
Menon, U., & Jacobs, I. J. (2000) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2000.00107.x · Cited by 73
Self-citationGallagher, N. J., Eliopoulos, A. G., Agathangelo, A., Oates, J., Crocker, J., & Young, L. S. (2002) · Molecular Pathology · doi:10.1136/mp.55.2.110 · Cited by 69
Rauvala, M., Puistola, U., & Turpeenniemi-Hujanen, T. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.07.009 · Cited by 64
A serum based analysis of ovarian epithelial tumorigenesis
Nolen, B. M., Marrangoni, A., Velikokhatnaya, L., Prosser, D., Winans, M. T., Gorelik, E., & Lokshin, A. E. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.09.043 · Cited by 53
Self-citationSeow, K., Juan, C., Hsu, Y.-P., Ho, L., Wang, Y.-Y., & Hwang, J. (2004) · Human Reproduction · doi:10.1093/humrep/deh589 · Cited by 52
Etiology, biology, and epidemiology of ovarian cancer
Baker, T. R., & Piver, M. S. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100403 · Cited by 43
Serum lipids concentration in women with benign and malignant ovarian tumours
Gadomska, H., Grzechocińska, B., Janecki, J., Nowicka, G., Powolny, M., & MARIANOWSKI, L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.02.045 · Cited by 39
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum
Linkov, F. Y., Gu, Y., Arslan, A. A., Liu, M., Shore, R. E., Velikokhatnaya, L., Koenig, K. L., Toniolo, P. G., Marrangoni, A., Yurkovetsky, Z. R., et al. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0146 · Cited by 33
Self-citationMarkers of Angiogenesis in Ovarian Cancer
Merritt, W. M., & Sood, A. K. (2007) · Disease Markers · doi:10.1155/2007/257602 · Cited by 33
BOTTOMLEY (1998) · European Journal of Cancer Care · doi:10.1046/j.1365-2354.1998.00064.x · Cited by 28
Reproducibility of Serum Pituitary Hormones in Women
Arslan, A. A., Gu, Y., Zeleniuch‐Jacquotte, A., Koenig, K. L., Liu, M., Velikokhatnaya, L., Shore, R. E., Toniolo, P. G., Linkov, F. Y., & Lokshin, A. E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0103 · Cited by 21
Self-citationAngiogenesis in ovarian cancer: Molecular pathology and therapeutic strategies
Paley, P. J. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0078-z · Cited by 18
MPO and Cytokines in the Serum of Cancer Patients in the Context ofCandidaColonization and Infection
Kozioł-Montewka, M., Magryś, A., Paluch-Oleś, J., Bogut, A., Buczynski, K., & Jabłonka, S. (2006) · Immunological Investigations · doi:10.1080/08820130600616540 · Cited by 12
Cited by
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 474
Jokerst, J. V., Cole, A. J., Van de Sompel, D., & Gambhir, S. S. (2012) · ACS Nano · doi:10.1021/nn304347g · Cited by 397
Stacking machine learning algorithms for biomarker-based preoperative diagnosis of a pelvic mass
Shaw, R., Lokshin, A. E., Miller, M. C., Messerlian-Lambert, G., & Moore, R. G. (2022) · Cancers · doi:10.3390/cancers14051291 · Cited by 16
“, Austin, TX, USA), as previously described [15].”
Self-citation
Metadata
- Authors
- Yurkovetsky, Z., Skates, S., Lomakin, A., Nolen, B., Pulsipher, T., Modugno, F., Marks, J., Godwin, A., Gorelik, E., Jacobs, I., Menon, U., Lu, K., Badgwell, D., Bast, R. C., & Lokshin, A. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-05-01
- Volume
- 28
- Issue
- 13
- Pages
- 2159-2166
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2145803449
- Cited by
- 274
- References
- 55
- FWCI
- 35.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.